Loading clinical trials...
Loading clinical trials...
Pilot Study to Understand the Feasibility of Implementing a Wearable Device Cueing System Following Bone Marrow Transplant
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay. Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move. Aim 2. To receive participant feedback on their experience participating in the study.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Froedtert Hospital
Milwaukee, Wisconsin, United States
Start Date
October 28, 2024
Primary Completion Date
January 21, 2025
Completion Date
September 1, 2025
Last Updated
February 14, 2025
15
ESTIMATED participants
exercise intervention
BEHAVIORAL
Lead Sponsor
Medical College of Wisconsin
NCT05873205
NCT07148180
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions